iConsensus has ended. iConsensus (2018-2022) was a collaborative research consortium formed by experts from academia and industry.
The consortium was developing an integrated control and sensing platform for production of biopharmaceuticals, vaccines and advanced therapies.
We believe that our platform is a key element for achieving faster and safer production of pharmaceuticals, more cost-effective development and manufacturing processes.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777397. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
The communication reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.